Matulane (procarbazine hydrochloride) / Leadiant Biosci 
Welcome,         Profile    Billing    Logout  
 0 Diseases   16 Trials   16 Trials   475 News 
23 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Matulane (procarbazine hydrochloride) / Leadiant Biosci
2010-022844-19: Randomized phase III study of a treatment driven by early PET response compared to a treatment not monitored by early PET in patients with Ann Arbor Stage III-IV or high risk IIB Hodgkin lymphoma

Ongoing
3
810
Europe
Bleomycin, Prednisone, Vincristine, Doxorubicin, Cyclophosphamide, Dacarbazine, Etoposide, Procarbazine, Vinblastine, Powder for solution for injection, Tablet, Solution for injection, Powder for solution for infusion, Solution for infusion, Capsule*
CHU de Dijon
Hodgkin Lymphoma not previously treated
 
 
NCT00379041: Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

Active, not recruiting
3
1158
NA
bleomycin sulfate, doxorubicin hydrochloride, mechlorethamine hydrochloride, prednisone, procarbazine hydrochloride, vinblastine sulfate, vincristine sulfate, radiation therapy
European Organisation for Research and Treatment of Cancer - EORTC
Lymphoma
10/98
 
NCT00002462: RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Active, not recruiting
3
615
Europe, RoW
bleomycin sulfate, doxorubicin hydrochloride, mechlorethamine hydrochloride, prednisone, procarbazine hydrochloride, vinblastine sulfate, vincristine sulfate, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy, radiation therapy
European Organisation for Research and Treatment of Cancer - EORTC
Lymphoma
05/00
 
2007-003187-22: HD18 for advanced stages HD18 für fortgeschrittene Stadien

 
3
1600
Europe
Bleomycin, Etoposide, Doxorubicine, Cyclophosphamide, Vincristine, Procarbazine, Prednisone, Bleomycin, Etoposid, Doxorubicin, Endoxan, Oncovin, Procarbazine, Prednisone, Bleomycin, Etoposid, Doxorubicin, Endoxan, Oncovin, Procarbazine, Prednisone
University of Cologne, VU University Medical Center, , Deutsche Krebshilfe
Hodgkin´s lymphomaadvanced stage
 
 
RATHL, NCT00678327 / 2007-006064-30: Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

Completed
3
1202
Europe
bleomycin sulfate, filgrastim, pegfilgrastim, cyclophosphamide, dacarbazine, doxorubicin hydrochloride, etoposide, prednisolone, procarbazine hydrochloride, vinblastine sulfate, vincristine sulfate
University College, London, Cancer Research UK, Cancer Research UK & UCL Cancer Trials Centre
Lymphoma
01/16
05/24

Active, not recruiting
3
1500
Europe
Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone, Brentuximab Vedotin, Dacarbazine, Dexamethasone
University of Cologne
Classical Hodgkin Lymphoma
12/22
09/25
2020-001181-10: Age-adapted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy and maintenance therapy in fit elderly patients* with initial diagnosis of primary cerebral lymphoma. Altersadaptierte Hochdosis-Chemotherapie gefolgt von autologer Stammzelltransplantation oder konventioneller Chemotherapie und Erhaltungstherapie bei fitten älteren Patient*innen mit Erstdiagnose eines primären zerebralen Lymphoms

Not yet recruiting
3
310
Europe
Rituximab, Methotrexate, Cytarabine, Thiotepa, Busulfan, Procarbazine, Concentrate for solution for infusion, Solution for infusion, Powder for concentrate for solution for infusion, Capsule, hard
Medical Center - University of Freiburg, BMBF Federal Ministry of Education and Research
Primary diffuse large B-cell lymphoma of the central nervous system(PCNSL) is a rare lymphoma affecting only the central nervous systemcompartment. PCNSL patients are typically 60 years or older and havepoor prognoses. Considering the poor prognosis of this patientpopulation, this randomised phase III trial proposal is of great clinicalimportance to provide patients optimal treatment. Das primäre diffuse großzellige B-Zell-Lymphom des zentralenNervensystems (PCNSL) ist ein seltenes Lymphom, das nur das zentraleNervensystem betrifft. PCNSL-Patienten sind in der Regel 60 Jahre oderälter. In Anbetracht der schlechten Prognose dieser Patientengruppe istdiese randomisierte Phase-III-Studie von großer klinischer Bedeutung,um den Patienten eine optimale Behandlung zu bieten., The primary lymphoma of the central nervous system is a rare disease,which occurs only in the central nervous system and more often amongelderly patient, who have a poor prognosis. Das primäres Lymphom des zentralen Nervensystems ist ein seltenesLymphom, das nur das zentrale Nervensystem betrifft und bei Patientenab 60 Jahren öfter auftritt und eine schlechte Prognose hat., Diseases [C] - Blood and lymphatic diseases [C15]
 
 
PRIMA-CNS, NCT06830421: Adjusted High-dose Chemotherapy with Autologous Stem Cell Transplant Vs. Conventional Immunochemotherapy in Elderly PCNSL Patients

Recruiting
3
340
Europe
R-MP and Procarbazine maintenance, R-MTX/AraC (MARTA) induction followed by consolidating HCT-ASCT
University Hospital Freiburg, German Federal Ministry of Education and Research, University Hospital Tuebingen, Heinrich-Heine University, Duesseldorf, Klinikum Stuttgart, University of Kaiserslautern, University Hospital Munich, University Hospital Regensburg
Primary Central Nervous System Lymphoma
08/29
08/31
NCT00887146 / 2008-007295-14: Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Active, not recruiting
3
305
Europe, Canada, US
concomitant temozolomide (TMZ), radiotherapy, procarbazine, adjuvant temozolomide (TMZ), CCNU, vincristine
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), European Organisation for Research and Treatment Center (EORTC), Canadian Cancer Trials Group
Brain and Central Nervous System Tumors
10/25
10/25
ImproveCodel, NCT05331521: A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).

Recruiting
3
406
Europe
CETEG, Lomustine (CCNU) and Temozolomide, PCV, Procarbazine, Lomustine and Vincristine, RT, Radiotherapy
University Hospital Heidelberg, Universitätsmedizin Mannheim, Ruhr University of Bochum
Oligodendroglioma
03/31
03/31
AHOD2131, NCT05675410: A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Recruiting
3
1875
Canada, US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bleomycin Sulfate, Blanoxan, BleMomycine, Blenoxane, Bleo-cell, Bleo-S, Bleocin, Bleolem, Bleomycin Sulfas, Bleomycin Sulphate, Bleomycini Sulfas, Blexane, Oil Bleo, Brentuximab Vedotin, ADC SGN-35, Adcetris, Anti-CD30 Antibody-Drug Conjugate SGN-35, Anti-CD30 Monoclonal Antibody-MMAE SGN-35, Anti-CD30 Monoclonal Antibody-Monomethylauristatin E SGN-35, cAC10-vcMMAE, SGN 35, SGN-35, SGN35, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B 518, B-518, B518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR 138719, WR- 138719, WR-138719, WR138719, Dacarbazine, 4-(Dimethyltriazeno)imidazole-5-carboxamide, 5-(Dimethyltriazeno)imidazole-4-carboxamide, Asercit, Biocarbazine, Dacarbazina, Dacarbazina Almirall, Dacarbazine - DTIC, Dacatic, Dakarbazin, Deticene, Detimedac, DIC, Dimethyl (triazeno) imidazolecarboxamide, Dimethyl Triazeno Imidazol Carboxamide, Dimethyl Triazeno Imidazole Carboxamide, dimethyl-triazeno-imidazole carboxamide, Dimethyl-triazeno-imidazole-carboximide, DTIC, DTIC-Dome, Fauldetic, Imidazole Carboxamide, Imidazole Carboxamide Dimethyltriazeno, WR-139007, Doxorubicin Hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI), ADM, Adriacin, Adriamycin, Adriamycin Hydrochloride, Adriamycin PFS, Adriamycin RDF, ADRIAMYCIN, HYDROCHLORIDE, Adriamycine, Adriblastina, Adriblastine, Adrimedac, Chloridrato de Doxorrubicina, DOX, DOXO-CELL, Doxolem, Doxorubicin HCl, Doxorubicin.HCl, Doxorubin, Farmiblastina, FI 106, FI-106, FI106, hydroxydaunorubicin, Rubex, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP 16213, VP-16, VP-16-213, VP-16213, VP16, VP16213, Etoposide Phosphate, Etopophos, Fludeoxyglucose F-18, 18FDG, FDG, Fludeoxyglucose (18F), fludeoxyglucose F 18, Fludeoxyglucose F18, Fluorine-18 2-Fluoro-2-deoxy-D-Glucose, Fluorodeoxyglucose F18, Involved-site Radiation Therapy, ISRT, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, PT, Prednisolone, (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione, .delta.1-Hydrocortisone, Adnisolone, Aprednislon, Capsoid, Cortalone, Cortisolone, Dacortin H, Decaprednil, Decortin H, Delta(1)Hydrocortisone, Delta- Cortef, Delta-Cortef, Delta-Diona, Delta-F, Delta-Phoricol, Delta1-dehydro-hydrocortisone, Deltacortril, Deltahydrocortisone, Deltasolone, Deltidrosol, Dhasolone, Di-Adreson-F, Dontisolon D, Estilsona, Fisopred, Frisolona, Gupisone, Hostacortin H, Hydeltra, Hydeltrasol, Klismacort, Kuhlprednon, Lenisolone, Lepi-Cortinolo, Linola-H N, Linola-H-Fett N, Longiprednil, Metacortandralone, Meti Derm, Meticortelone, Opredsone, Panafcortelone, Precortisyl, Pred-Clysma, Predeltilone, Predni-Coelin, Predni-Helvacort, Prednicortelone, Prednisolonum, Prelone, Prenilone, Sterane, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Procarbazine Hydrochloride, Benzamide, N-(1-methylethyl)-4-[(2-methylhydrazino) methyl]-, monohydrochloride (9CI), Ibenzmethyzine hydrochloride, Matulane, MIH hydrochloride, Natulan, Natulanar, Natunalar, NCI C01810, NCI-C01810, NCIC01810, p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide hydrochloride, p-Toluamide, N-isopropyl-.alpha.-(2-methylhydrazino)-, monohydrochloride (8CI), PCB, PCB Hydrochloride, PCZ, Ro 4 6467/1, Ro 4-6467/1, Questionnaire Administration, Vinblastine Sulfate, 29060 LE, 29060-LE, Exal, Velban, Velbe, Velsar, VINCALEUKOBLASTINE, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
National Cancer Institute (NCI)
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
04/31
04/31
NCT00059956: Immunotherapy Combined With Chemotherapy Followed by Radiation Therapy and Chemotherapy in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Active, not recruiting
2
US
rituximab, cytarabine, methotrexate, procarbazine hydrochloride, vincristine sulfate, radiation therapy
Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Lymphoma
 
 
2019-003632-23: Lenalidomide and Ibrutinib in association with R-MPV first-line treatment of Primary Central Nervous System Lymphoma for patients aged 18 to 60 Lénalidomide et Ibrutinib en association avec le R-MPV en traitement d’induction de première ligne pour les patients âgés de 18 à 60 ans présentant un lymphome primitif du système nerveux central (LCP).

Not yet recruiting
2
128
Europe
Ibrutinib 140 mg, Rituximab, Methotrexate, Procarbazine, Vincristine, Prednisone, Capsule, hard, Solution for infusion, Capsule, Tablet, Revlimid 5 mg, Revlimid 10 mg, Imbruvica 140 mg
Institut Curie, PHRC-K 2018 Public Health Grant, CELGENE SAS, JANSSEN-CILAG, KEOCYT SAS
Primary Central Nervous System Lymphoma (PCNSL) in patients aged 18 to 60, in first-line treatment Lymphome primitif du système nerveux central chez des patients âgés de 18 à 60 ans, en traitement de première ligne, Primary Central Nervous System Lymphoma in patients aged 18 to 60, first treatment Lymphome primitif du système nerveux central chez des patients âgés de 18 à 60 ans, 1er traitement, Diseases [C] - Cancer [C04]
 
 
2019-004053-91: BRIOChe: A trial looking at re-irradiation and chemotherapy in patients with recurrent glioblastoma.

Not yet recruiting
2
70
Europe
Lomustine, Procarbazine, Vincristine, Capsule, Injection, Lomustine medac, Vincristine
University of Leeds, The Jon Moulton Charity Trust
Recurrent Glioblastoma, Brain tumour, Diseases [C] - Cancer [C04]
 
 
NCT00596154: Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

Checkmark P2 data - ASCO
Jun 2012 - Jun 2012: P2 data - ASCO
Completed
2
33
US
Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide, During each cycle, you will receive Rituximab typically as an outpatient on day 1 and then be, admitted on day 2 to receive the other chemotherapy. You will be in the hospital for about 5 days and will be re-admitted to the hospital about 9 days, later to start the next cycle. After each cycle of chemotherapy you will take a medicine called G-CSF to protect you against, infection. PBPCs will be collected when determined by your doctor and may occur with cycle 1 or cycle 2., You will be admitted again for the high-dose chemotherapy and will receive supportive, medications to help avoid complications, including antibiotics and blood transfusions. Three, drugs, Busulfan, Thiotepa, and Cyclophosphamide will be given to you over 8 days. After a, rest period of approximately 1-2 days, we will give your PBPCs (or bone marrow) back to you, by vein. You will be in the hospital for at least 3 weeks.
Memorial Sloan Kettering Cancer Center
CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma
02/23
02/23
NCT05425654: RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL

Recruiting
2
30
RoW
Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide, Busulfan, Carmustine, and Cyclophosphamide
National Research Center for Hematology, Russia
Primary CNS Lymphoma
05/23
05/26
KEYNOTE-C11, NCT05008224 / 2021-001244-95: Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/)

Checkmark Presentation of data from KEYNOTE-C11 trial for 1L Classic Hodgkin Lymphoma at ASH 2022
Nov 2022 - Nov 2022: Presentation of data from KEYNOTE-C11 trial for 1L Classic Hodgkin Lymphoma at ASH 2022
Completed
2
146
Europe, Canada, US, RoW
Pembrolizumab, MK-3475, SCH 900475, KEYTRUDA®, Doxorubicin, Adriamycin, DOXIL®, Rubex®, Vinblastine, Alkaban-AQ®, Velban®, Dacarbazine, Dtic-Dome®, Bleomycin, Blenoxane®, Etoposide, Toposar®, VePesid®, Etopophos®, VP-16, Etoposide phosphate, Cyclophosphamide, Neosar®, Cytoxan®, Vincristine, Oncovin®, Vincasar PFS®, Procarbazine, Matulane®, Prednisone, Liquid Pred®, Meticorten®, Orasone®, Deltasone®
Merck Sharp & Dohme LLC, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc
Classical Hodgkin Lymphoma
10/23
05/24
FIORELLA, NCT03495960 / 2016-003116-12: Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System

Completed
2
72
Europe
Rituximab, Methotrexate, Procarbazine, Lenalidomide, Radiotherapy, Temozolomide
International Extranodal Lymphoma Study Group (IELSG)
Primary Central Nervous System Lymphoma
12/24
12/24
NCT07015242: A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Not yet recruiting
2
65
Europe, US
Rituximab, Methotrexate, Procarbazine, Temozolomide, Liso-cel, JCAR017, Breyanzi, Fludarabine, Cyclophosphamide, Calcium folinate, Leucovorin
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Lymphoma
01/28
01/29
NCT03576378 / 2017-003689-28: BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)

Active, not recruiting
1/2
41
Europe
BrentuximabVedotin (BV), cyclophosphamide, procarbazine, prednisone, etoposide, mitoxantrone
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea, Takeda
Hodgkin Lymphoma
10/23
10/24
R-MPV, NCT04446962 / 2019-003632-23: LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin

Active, not recruiting
1/2
118
Europe
Lenalidomide, Revlimid, Ibrutinib, Imbruvica
Institut Curie, National Cancer Institute, France
Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms, Primary
08/25
08/35
NCT02315326: Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)

Checkmark ASCO 2016
May 2016 - May 2016: ASCO 2016
Recruiting
1/2
109
US
Ibrutinib, Imbruvica™, HD- Methotrexate (MTX), Rituximab + HD- Methotrexate (MTX), procarbazine
Memorial Sloan Kettering Cancer Center, Pharmacyclics LLC., Janssen Biotech, Inc.
Adult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL), Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)
12/26
12/26
NCT06541665: Phase I Study Evaluating Tolerability, Safety, Pharmacokinetics, and Efficacy of Combined ONO-4059 and R-MPV Therapy for PCNSL

Active, not recruiting
1
20
Japan
ONO-4059, Tirabrutinib Hydrochloride, Rituximab, Methotrexate, Procarbazine, Vincristine
Ono Pharmaceutical Co. Ltd
Primary Central Nervous System Lymphoma
04/28
08/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Matulane (procarbazine hydrochloride) / Leadiant Biosci
2010-022844-19: Randomized phase III study of a treatment driven by early PET response compared to a treatment not monitored by early PET in patients with Ann Arbor Stage III-IV or high risk IIB Hodgkin lymphoma

Ongoing
3
810
Europe
Bleomycin, Prednisone, Vincristine, Doxorubicin, Cyclophosphamide, Dacarbazine, Etoposide, Procarbazine, Vinblastine, Powder for solution for injection, Tablet, Solution for injection, Powder for solution for infusion, Solution for infusion, Capsule*
CHU de Dijon
Hodgkin Lymphoma not previously treated
 
 
NCT00379041: Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

Active, not recruiting
3
1158
NA
bleomycin sulfate, doxorubicin hydrochloride, mechlorethamine hydrochloride, prednisone, procarbazine hydrochloride, vinblastine sulfate, vincristine sulfate, radiation therapy
European Organisation for Research and Treatment of Cancer - EORTC
Lymphoma
10/98
 
NCT00002462: RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Active, not recruiting
3
615
Europe, RoW
bleomycin sulfate, doxorubicin hydrochloride, mechlorethamine hydrochloride, prednisone, procarbazine hydrochloride, vinblastine sulfate, vincristine sulfate, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy, radiation therapy
European Organisation for Research and Treatment of Cancer - EORTC
Lymphoma
05/00
 
2007-003187-22: HD18 for advanced stages HD18 für fortgeschrittene Stadien

 
3
1600
Europe
Bleomycin, Etoposide, Doxorubicine, Cyclophosphamide, Vincristine, Procarbazine, Prednisone, Bleomycin, Etoposid, Doxorubicin, Endoxan, Oncovin, Procarbazine, Prednisone, Bleomycin, Etoposid, Doxorubicin, Endoxan, Oncovin, Procarbazine, Prednisone
University of Cologne, VU University Medical Center, , Deutsche Krebshilfe
Hodgkin´s lymphomaadvanced stage
 
 
RATHL, NCT00678327 / 2007-006064-30: Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

Completed
3
1202
Europe
bleomycin sulfate, filgrastim, pegfilgrastim, cyclophosphamide, dacarbazine, doxorubicin hydrochloride, etoposide, prednisolone, procarbazine hydrochloride, vinblastine sulfate, vincristine sulfate
University College, London, Cancer Research UK, Cancer Research UK & UCL Cancer Trials Centre
Lymphoma
01/16
05/24

Active, not recruiting
3
1500
Europe
Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone, Brentuximab Vedotin, Dacarbazine, Dexamethasone
University of Cologne
Classical Hodgkin Lymphoma
12/22
09/25
2020-001181-10: Age-adapted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy and maintenance therapy in fit elderly patients* with initial diagnosis of primary cerebral lymphoma. Altersadaptierte Hochdosis-Chemotherapie gefolgt von autologer Stammzelltransplantation oder konventioneller Chemotherapie und Erhaltungstherapie bei fitten älteren Patient*innen mit Erstdiagnose eines primären zerebralen Lymphoms

Not yet recruiting
3
310
Europe
Rituximab, Methotrexate, Cytarabine, Thiotepa, Busulfan, Procarbazine, Concentrate for solution for infusion, Solution for infusion, Powder for concentrate for solution for infusion, Capsule, hard
Medical Center - University of Freiburg, BMBF Federal Ministry of Education and Research
Primary diffuse large B-cell lymphoma of the central nervous system(PCNSL) is a rare lymphoma affecting only the central nervous systemcompartment. PCNSL patients are typically 60 years or older and havepoor prognoses. Considering the poor prognosis of this patientpopulation, this randomised phase III trial proposal is of great clinicalimportance to provide patients optimal treatment. Das primäre diffuse großzellige B-Zell-Lymphom des zentralenNervensystems (PCNSL) ist ein seltenes Lymphom, das nur das zentraleNervensystem betrifft. PCNSL-Patienten sind in der Regel 60 Jahre oderälter. In Anbetracht der schlechten Prognose dieser Patientengruppe istdiese randomisierte Phase-III-Studie von großer klinischer Bedeutung,um den Patienten eine optimale Behandlung zu bieten., The primary lymphoma of the central nervous system is a rare disease,which occurs only in the central nervous system and more often amongelderly patient, who have a poor prognosis. Das primäres Lymphom des zentralen Nervensystems ist ein seltenesLymphom, das nur das zentrale Nervensystem betrifft und bei Patientenab 60 Jahren öfter auftritt und eine schlechte Prognose hat., Diseases [C] - Blood and lymphatic diseases [C15]
 
 
PRIMA-CNS, NCT06830421: Adjusted High-dose Chemotherapy with Autologous Stem Cell Transplant Vs. Conventional Immunochemotherapy in Elderly PCNSL Patients

Recruiting
3
340
Europe
R-MP and Procarbazine maintenance, R-MTX/AraC (MARTA) induction followed by consolidating HCT-ASCT
University Hospital Freiburg, German Federal Ministry of Education and Research, University Hospital Tuebingen, Heinrich-Heine University, Duesseldorf, Klinikum Stuttgart, University of Kaiserslautern, University Hospital Munich, University Hospital Regensburg
Primary Central Nervous System Lymphoma
08/29
08/31
NCT00887146 / 2008-007295-14: Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma

Active, not recruiting
3
305
Europe, Canada, US
concomitant temozolomide (TMZ), radiotherapy, procarbazine, adjuvant temozolomide (TMZ), CCNU, vincristine
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), European Organisation for Research and Treatment Center (EORTC), Canadian Cancer Trials Group
Brain and Central Nervous System Tumors
10/25
10/25
ImproveCodel, NCT05331521: A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).

Recruiting
3
406
Europe
CETEG, Lomustine (CCNU) and Temozolomide, PCV, Procarbazine, Lomustine and Vincristine, RT, Radiotherapy
University Hospital Heidelberg, Universitätsmedizin Mannheim, Ruhr University of Bochum
Oligodendroglioma
03/31
03/31
AHOD2131, NCT05675410: A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Recruiting
3
1875
Canada, US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bleomycin Sulfate, Blanoxan, BleMomycine, Blenoxane, Bleo-cell, Bleo-S, Bleocin, Bleolem, Bleomycin Sulfas, Bleomycin Sulphate, Bleomycini Sulfas, Blexane, Oil Bleo, Brentuximab Vedotin, ADC SGN-35, Adcetris, Anti-CD30 Antibody-Drug Conjugate SGN-35, Anti-CD30 Monoclonal Antibody-MMAE SGN-35, Anti-CD30 Monoclonal Antibody-Monomethylauristatin E SGN-35, cAC10-vcMMAE, SGN 35, SGN-35, SGN35, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B 518, B-518, B518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR 138719, WR- 138719, WR-138719, WR138719, Dacarbazine, 4-(Dimethyltriazeno)imidazole-5-carboxamide, 5-(Dimethyltriazeno)imidazole-4-carboxamide, Asercit, Biocarbazine, Dacarbazina, Dacarbazina Almirall, Dacarbazine - DTIC, Dacatic, Dakarbazin, Deticene, Detimedac, DIC, Dimethyl (triazeno) imidazolecarboxamide, Dimethyl Triazeno Imidazol Carboxamide, Dimethyl Triazeno Imidazole Carboxamide, dimethyl-triazeno-imidazole carboxamide, Dimethyl-triazeno-imidazole-carboximide, DTIC, DTIC-Dome, Fauldetic, Imidazole Carboxamide, Imidazole Carboxamide Dimethyltriazeno, WR-139007, Doxorubicin Hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI), ADM, Adriacin, Adriamycin, Adriamycin Hydrochloride, Adriamycin PFS, Adriamycin RDF, ADRIAMYCIN, HYDROCHLORIDE, Adriamycine, Adriblastina, Adriblastine, Adrimedac, Chloridrato de Doxorrubicina, DOX, DOXO-CELL, Doxolem, Doxorubicin HCl, Doxorubicin.HCl, Doxorubin, Farmiblastina, FI 106, FI-106, FI106, hydroxydaunorubicin, Rubex, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP 16213, VP-16, VP-16-213, VP-16213, VP16, VP16213, Etoposide Phosphate, Etopophos, Fludeoxyglucose F-18, 18FDG, FDG, Fludeoxyglucose (18F), fludeoxyglucose F 18, Fludeoxyglucose F18, Fluorine-18 2-Fluoro-2-deoxy-D-Glucose, Fluorodeoxyglucose F18, Involved-site Radiation Therapy, ISRT, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, PT, Prednisolone, (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione, .delta.1-Hydrocortisone, Adnisolone, Aprednislon, Capsoid, Cortalone, Cortisolone, Dacortin H, Decaprednil, Decortin H, Delta(1)Hydrocortisone, Delta- Cortef, Delta-Cortef, Delta-Diona, Delta-F, Delta-Phoricol, Delta1-dehydro-hydrocortisone, Deltacortril, Deltahydrocortisone, Deltasolone, Deltidrosol, Dhasolone, Di-Adreson-F, Dontisolon D, Estilsona, Fisopred, Frisolona, Gupisone, Hostacortin H, Hydeltra, Hydeltrasol, Klismacort, Kuhlprednon, Lenisolone, Lepi-Cortinolo, Linola-H N, Linola-H-Fett N, Longiprednil, Metacortandralone, Meti Derm, Meticortelone, Opredsone, Panafcortelone, Precortisyl, Pred-Clysma, Predeltilone, Predni-Coelin, Predni-Helvacort, Prednicortelone, Prednisolonum, Prelone, Prenilone, Sterane, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Procarbazine Hydrochloride, Benzamide, N-(1-methylethyl)-4-[(2-methylhydrazino) methyl]-, monohydrochloride (9CI), Ibenzmethyzine hydrochloride, Matulane, MIH hydrochloride, Natulan, Natulanar, Natunalar, NCI C01810, NCI-C01810, NCIC01810, p-(N'-methylhydrazinomethyl)-N-isopropylbenzamide hydrochloride, p-Toluamide, N-isopropyl-.alpha.-(2-methylhydrazino)-, monohydrochloride (8CI), PCB, PCB Hydrochloride, PCZ, Ro 4 6467/1, Ro 4-6467/1, Questionnaire Administration, Vinblastine Sulfate, 29060 LE, 29060-LE, Exal, Velban, Velbe, Velsar, VINCALEUKOBLASTINE, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
National Cancer Institute (NCI)
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
04/31
04/31
NCT00059956: Immunotherapy Combined With Chemotherapy Followed by Radiation Therapy and Chemotherapy in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Active, not recruiting
2
US
rituximab, cytarabine, methotrexate, procarbazine hydrochloride, vincristine sulfate, radiation therapy
Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Lymphoma
 
 
2019-003632-23: Lenalidomide and Ibrutinib in association with R-MPV first-line treatment of Primary Central Nervous System Lymphoma for patients aged 18 to 60 Lénalidomide et Ibrutinib en association avec le R-MPV en traitement d’induction de première ligne pour les patients âgés de 18 à 60 ans présentant un lymphome primitif du système nerveux central (LCP).

Not yet recruiting
2
128
Europe
Ibrutinib 140 mg, Rituximab, Methotrexate, Procarbazine, Vincristine, Prednisone, Capsule, hard, Solution for infusion, Capsule, Tablet, Revlimid 5 mg, Revlimid 10 mg, Imbruvica 140 mg
Institut Curie, PHRC-K 2018 Public Health Grant, CELGENE SAS, JANSSEN-CILAG, KEOCYT SAS
Primary Central Nervous System Lymphoma (PCNSL) in patients aged 18 to 60, in first-line treatment Lymphome primitif du système nerveux central chez des patients âgés de 18 à 60 ans, en traitement de première ligne, Primary Central Nervous System Lymphoma in patients aged 18 to 60, first treatment Lymphome primitif du système nerveux central chez des patients âgés de 18 à 60 ans, 1er traitement, Diseases [C] - Cancer [C04]
 
 
2019-004053-91: BRIOChe: A trial looking at re-irradiation and chemotherapy in patients with recurrent glioblastoma.

Not yet recruiting
2
70
Europe
Lomustine, Procarbazine, Vincristine, Capsule, Injection, Lomustine medac, Vincristine
University of Leeds, The Jon Moulton Charity Trust
Recurrent Glioblastoma, Brain tumour, Diseases [C] - Cancer [C04]
 
 
NCT00596154: Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

Checkmark P2 data - ASCO
Jun 2012 - Jun 2012: P2 data - ASCO
Completed
2
33
US
Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide, During each cycle, you will receive Rituximab typically as an outpatient on day 1 and then be, admitted on day 2 to receive the other chemotherapy. You will be in the hospital for about 5 days and will be re-admitted to the hospital about 9 days, later to start the next cycle. After each cycle of chemotherapy you will take a medicine called G-CSF to protect you against, infection. PBPCs will be collected when determined by your doctor and may occur with cycle 1 or cycle 2., You will be admitted again for the high-dose chemotherapy and will receive supportive, medications to help avoid complications, including antibiotics and blood transfusions. Three, drugs, Busulfan, Thiotepa, and Cyclophosphamide will be given to you over 8 days. After a, rest period of approximately 1-2 days, we will give your PBPCs (or bone marrow) back to you, by vein. You will be in the hospital for at least 3 weeks.
Memorial Sloan Kettering Cancer Center
CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma
02/23
02/23
NCT05425654: RL-MPV Followed by BBC HCT Using Autologous Stem Cells and Maintenance Therapy With Nivolumab for Newly Diagnosed PCNSL

Recruiting
2
30
RoW
Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide, Busulfan, Carmustine, and Cyclophosphamide
National Research Center for Hematology, Russia
Primary CNS Lymphoma
05/23
05/26
KEYNOTE-C11, NCT05008224 / 2021-001244-95: Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/)

Checkmark Presentation of data from KEYNOTE-C11 trial for 1L Classic Hodgkin Lymphoma at ASH 2022
Nov 2022 - Nov 2022: Presentation of data from KEYNOTE-C11 trial for 1L Classic Hodgkin Lymphoma at ASH 2022
Completed
2
146
Europe, Canada, US, RoW
Pembrolizumab, MK-3475, SCH 900475, KEYTRUDA®, Doxorubicin, Adriamycin, DOXIL®, Rubex®, Vinblastine, Alkaban-AQ®, Velban®, Dacarbazine, Dtic-Dome®, Bleomycin, Blenoxane®, Etoposide, Toposar®, VePesid®, Etopophos®, VP-16, Etoposide phosphate, Cyclophosphamide, Neosar®, Cytoxan®, Vincristine, Oncovin®, Vincasar PFS®, Procarbazine, Matulane®, Prednisone, Liquid Pred®, Meticorten®, Orasone®, Deltasone®
Merck Sharp & Dohme LLC, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc
Classical Hodgkin Lymphoma
10/23
05/24
FIORELLA, NCT03495960 / 2016-003116-12: Study on Tailored Treatment in Elderly Patients With Newly Diagnosed Primary Lymphoma of Central Nervous System

Completed
2
72
Europe
Rituximab, Methotrexate, Procarbazine, Lenalidomide, Radiotherapy, Temozolomide
International Extranodal Lymphoma Study Group (IELSG)
Primary Central Nervous System Lymphoma
12/24
12/24
NCT07015242: A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Not yet recruiting
2
65
Europe, US
Rituximab, Methotrexate, Procarbazine, Temozolomide, Liso-cel, JCAR017, Breyanzi, Fludarabine, Cyclophosphamide, Calcium folinate, Leucovorin
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Lymphoma
01/28
01/29
NCT03576378 / 2017-003689-28: BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL)

Active, not recruiting
1/2
41
Europe
BrentuximabVedotin (BV), cyclophosphamide, procarbazine, prednisone, etoposide, mitoxantrone
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea, Takeda
Hodgkin Lymphoma
10/23
10/24
R-MPV, NCT04446962 / 2019-003632-23: LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin

Active, not recruiting
1/2
118
Europe
Lenalidomide, Revlimid, Ibrutinib, Imbruvica
Institut Curie, National Cancer Institute, France
Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms, Primary
08/25
08/35
NCT02315326: Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)

Checkmark ASCO 2016
May 2016 - May 2016: ASCO 2016
Recruiting
1/2
109
US
Ibrutinib, Imbruvica™, HD- Methotrexate (MTX), Rituximab + HD- Methotrexate (MTX), procarbazine
Memorial Sloan Kettering Cancer Center, Pharmacyclics LLC., Janssen Biotech, Inc.
Adult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL), Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)
12/26
12/26
NCT06541665: Phase I Study Evaluating Tolerability, Safety, Pharmacokinetics, and Efficacy of Combined ONO-4059 and R-MPV Therapy for PCNSL

Active, not recruiting
1
20
Japan
ONO-4059, Tirabrutinib Hydrochloride, Rituximab, Methotrexate, Procarbazine, Vincristine
Ono Pharmaceutical Co. Ltd
Primary Central Nervous System Lymphoma
04/28
08/28

Download Options